-
European Journal of Preventive... Mar 2018
Topics: Cardiovascular Diseases; Diabetes Complications; Global Health; Humans; Morbidity; Survival Rate
PubMed: 29488409
DOI: 10.1177/2047487318762643 -
The American Journal of Cardiology Dec 2023
Topics: Humans; Aged; Balloon Valvuloplasty; Survival Rate; Aortic Valve Stenosis; Perfusion
PubMed: 37918225
DOI: 10.1016/j.amjcard.2023.09.059 -
Resuscitation Oct 2021To evaluate the relationship between the accessibility of automatic external defibrillators (AEDs) and the survival rate of patients who have out-of-hospital cardiac... (Meta-Analysis)
Meta-Analysis
OBJECTIVE
To evaluate the relationship between the accessibility of automatic external defibrillators (AEDs) and the survival rate of patients who have out-of-hospital cardiac arrest (OHCA).
METHODS
The systematic review was conducted according to the Cochrane Handbook of Systematic Reviews. We searched the Chinese and English literature databases from 2009 to 2019. Study selection and data collection were conducted by three reviewers. One-month survival rates of OHCA with different AEDs accessibility were estimated using meta-analysis.
RESULTS
Overall 16 studies with 55,537 participants were included. The overall one-month survival rate for OHCA was 27.4%. The one-month survival rate was 35.2% for people receiving AEDs within 5 min, 36.6% between 5 min to 10 min, and 28.4% for longer than 10 min. By distance between the location of the AEDs and the location of the cardiac arrest, the one-month survival rate was 37.1% for those ≤100 m, 22.0% for 100 m-200 m, and 12.8% for >200 m, respectively. The one-month survival rate was 39.3% in schools, sports venues and airports compared with 23.5% in other sites. The number of AEDs allocation was positively correlated, while the time and distance were negatively correlated with the one-month survival rate adjusted for other factors, but they were all non-significant correlations.
CONCLUSION
The improvement of accessibility of AEDs may increase the survival rate of OHCA and the survival rate may be higher in playgrounds, airports, and schools equipped with AEDs. However, the strength of evidence was limited by the considerably heterogeneity of included studies. Verification of these findings in further studies is warranted.
Topics: Cardiopulmonary Resuscitation; Defibrillators; Humans; Out-of-Hospital Cardiac Arrest; Survival Rate
PubMed: 34453997
DOI: 10.1016/j.resuscitation.2021.08.035 -
Korean Journal of Radiology May 2022
Topics: Humans; Research Design; Survival Rate
PubMed: 35506526
DOI: 10.3348/kjr.2022.0061 -
Pediatrics May 2021Presence of a syndrome (or association) is predictive of poor survival in esophageal atresia (EA). However, most reports rely on historical patient outcomes, limiting...
BACKGROUND AND OBJECTIVES
Presence of a syndrome (or association) is predictive of poor survival in esophageal atresia (EA). However, most reports rely on historical patient outcomes, limiting their usefulness when estimating risk for neonates born today. We hypothesized improved syndromic EA survival due to advances in neonatal care.
METHODS
A retrospective single-center review of survival in 626 consecutive patients with EA from 1980 to 2017 was performed. Data were collected for recognized risk factors: preterm delivery; birth weight <1500 g; major cardiac disease; vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities (VACTERL); and non-VACTERL syndromes. Cox proportional hazards regression models were used to evaluate temporal trends in survival with respect to year of birth and syndromic EA.
RESULTS
Overall, 87% of 626 patients with EA survived, ranging from 82% in the 1980s to 91% in the 2010s. After adjusting for confounders, syndromic EA survival did not improve during the study, with no association found between year of birth and survival (hazard ratio [HR] 0.98, 95% confidence interval [CI]: 0.95-1.01). Aside from lethal non-VACTERL syndromes, patients with nonlethal non-VACTERL syndromes (HR 6.85, 95% CI: 3.50-13.41) and VACTERL syndrome (HR 3.02, 95% CI: 1.66-5.49) had a higher risk of death than those with nonsyndromic EA.
CONCLUSIONS
Survival of patients with syndromic EA has not improved, and patients with non-VACTERL syndromes have the highest risk of death. Importantly, this is independent of syndrome lethality, birth weight, and cardiac disease. This contemporary survival assessment will enable more accurate perinatal counseling of parents of patients with syndromic EA.
Topics: Esophageal Atresia; Female; Humans; Infant, Newborn; Male; Retrospective Studies; Survival Rate; Syndrome
PubMed: 33911029
DOI: 10.1542/peds.2020-029884 -
Cancer Treatment Reviews Nov 2007Adolescent cancer is the leading cause of non-accidental mortality in young people. The tumour types occurring most commonly in this age group are distinctive and differ... (Review)
Review
BACKGROUND
Adolescent cancer is the leading cause of non-accidental mortality in young people. The tumour types occurring most commonly in this age group are distinctive and differ markedly from those developing in younger children and older adults.
OBJECTIVE
The aim is to present survival data for the major types of cancer and for all malignancies combined in adolescents aged from 15 to 19 years, highlighting intercountry differences, temporal trends, and age/treatment regimen comparisons of survival rates.
RESULTS
Results from European and American data show that 5-year overall survival among adolescents with cancer is approximately 73-78%, close to that observed among children. As in paediatric series, there are geographical differences, with lower survival rates in Eastern European countries. Adolescents have substantially lower survival than children for acute lymphoid leukaemia, malignant non-Hodgkin lymphoma, Ewing's tumour, osteosarcoma, soft-tissue sarcoma. Temporal improvement in survival from children cancer is twice higher than survival from adolescents malignancies.
CONCLUSION
Several reasons could explain these geographical differences, such as better referral, greater availability of complex and expensive treatment regimens, reflecting variations in health care systems and resources. Age-group variations could be explained by differences in biology and in treatment regimen, and lack of participation in clinical trials. Some are inherent in the psychosocial characteristics of these patients, such as delays in seeking medical attention, poor compliance with treatment. It is necessary to focus on cancer in adolescence, as the new frontier in oncology, and adolescents with cancer must be now the subject of specific survival analyses.
Topics: Adolescent; Global Health; Humans; Neoplasms; Risk Factors; Survival Rate
PubMed: 17398011
DOI: 10.1016/j.ctrv.2006.12.007 -
Internal Medicine Journal May 2023
Topics: Humans; Pleural Effusion; Survival Rate
PubMed: 37222090
DOI: 10.1111/imj.16092 -
Harmful Algae Jul 2020Harmful algal blooms (HABs) have had harmful effects on the health of a wide range of organisms and are becoming a noteworthy risk to fisheries, human health and...
Survey of survival rate and histological alterations of gills and hepatopancreas of the Litopenaeus vannamei juveniles caused by exposure of Margalefidinium / Cochlodinium polykrikoides isolated from the Persian Gulf.
Harmful algal blooms (HABs) have had harmful effects on the health of a wide range of organisms and are becoming a noteworthy risk to fisheries, human health and wildlife around the globe. Although the lethal influences of dinoflagellate Margalefidinium / Cochlodinium polykrikoides have been well-documented for finfish, the impacts on decapod crustacean species, especially, Litopenaeus vannamei are poorly understood. Here, we examined the exposure of L. vannamei juveniles with different M. polykrikoides densities (T1: 1 × 10, T2: 2 × 10, T3: 3 × 10, T4: 9 × 10 and T5: 30 × 10 cells ml), in order to observe possible histological alterations in gills and hepatopancreas. After 96 h exposure, shrimp exhibited increased mortality and survival rate of juveniles in control group were meaningfully (P < 0.05) higher than treatments exposed to 9 × 10 and 30 × 10 cells ml of M. polykrikoides. The lowest survival observed in treatments T4 (95.56%) and T5 (82.20 %), respectively. The juveniles exposed to high densities of M. polykrikoides had flaccid bodies and gills were yellow in color with some black spots (melanization) in pereiopods. At the end of the experiment, shrimps' hepatopancreas and gills exhibited various histological alterations. The irregular appearance of the tubular structure of the hepatopancreas, R- and B-cells reduction, separation of epithelium and myoepithelial layer, ruptured epithelial cells and degeneration of tubules were detected in the hepatopancreas of shrimps exposed to 30 × 10 cells ml. In gills of shrimp exposed to 30 × 10 cells ml, alterations in epithelial structure, increases in the number of intercellular hemocytes, and changes in tissue structure were observed. Finally, findings suggest that M. polykrikoides blooms can lead to significant impacts on survival and major histological alterations in gills and hepatopancreas organs when the density of M. polykrikoides was over 9 × 10 cells ml.
Topics: Animals; Dinoflagellida; Gills; Hepatopancreas; Indian Ocean; Survival Rate
PubMed: 32732050
DOI: 10.1016/j.hal.2020.101856 -
Journal of Cancer Survivorship :... Mar 2007This paper provides an introduction to a new journal dedicated to research and practice that can improve the quality of health and well-being among cancer survivors...
This paper provides an introduction to a new journal dedicated to research and practice that can improve the quality of health and well-being among cancer survivors worldwide. Given the increased number of cancer survivors and the anticipated growth of this population, the development of new knowledge and innovative applications are more pressing than ever. Cancer survivorship is a major public health challenge. This paper provides a brief description of the target population and the rationale for such a journal. The scope and mission of this journal along with examples of potential topics are also presented. Justification is provided for both multidisciplinary and interdisciplinary perspectives. The Journal of Cancer Survivorship: Research and Practice invites submissions from researchers, research-oriented practitioners and those involved in innovative policy matters to submit their scholarly work to help improve the lives of cancer survivors.
Topics: Editorial Policies; Humans; Neoplasms; Quality of Life; Research; Survival Rate; Survivors
PubMed: 18648938
DOI: 10.1007/s11764-006-0001-y -
Journal of Medical Screening 2007Breast cancers detected between screening examinations can influence the sensitivity of a screening programme. Studies of the prognosis of these so-called interval...
OBJECTIVE
Breast cancers detected between screening examinations can influence the sensitivity of a screening programme. Studies of the prognosis of these so-called interval breast cancers show diverging results. We investigated the course of interval breast cancer over time in the Malmö Mammographic Screening Trial (MMST) 1976-86 and the Malmö Mammographic Service Screening Programme (MMSSP) 1990-99.
MATERIAL AND METHODS
Stage distribution and survival of interval cancers in MMSSP were compared with screen-detected and non-attender cancer cases in MMSSP, with interval cancers in MMST and with breast cancer cases in a non-screened population five years before the start of MMSSP (pre-screening cancer cases).
RESULTS
In MMSSP 1990-99, the interval cancers did not differ in stage distribution or survival compared with cancer cases in non-attenders, while screen-detected cancer cases had more favourable stage distribution and rate of survival than had the interval cancer cases. The MMST interval cancer cases, 1976-1986, had more favourable stage distribution but higher overall case fatality rate, relative risks (RR) 1.78 (1.00-3.20), and breast cancer case fatality rate, RR 2.05 (1.05-4.00), compared with the more recent MMSSP interval cancer cases. No significant difference in five-year survival was seen in the MMSSP interval cancer cases compared with pre-screening cancer cases not exposed to screening.
CONCLUSION
In this urban population invited to mammographic screening, the survival rate for women with interval cancer has improved over a period of 20 years. Further studies are needed to assess what factors might explain changes in the course of interval breast cancer.
Topics: Aged; Breast Neoplasms; Female; Humans; Mass Screening; Middle Aged; Prognosis; Survival Rate; Sweden; Time Factors
PubMed: 17925086
DOI: 10.1258/096914107782066239